LMSARCOMA DIRECT RESEARCH FOUNDATION (EIN 870763851) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

Edward Kurtz

Phone

9186376070

Tax Period

2024-01-01 to 2024-12-31

LMSARCOMA DIRECT RESEARCH FOUNDATION, founded in 2006, is a community nonprofit in the Science & Technology sector that reported $1.5M in total revenue in fiscal year 2024. Revenue surged 239% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.1M, a strong 77% operating margin.

Mission

To help find a cure for Leiomyosarcoma by creating a relationship with researchers in which we help fund projects that can lead to effective treatments. The secondary mission is to provide a forum for Patients and care givers to share information and access to the latest studies.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,445,845

Program Service Revenue $0

Investment Income $19,418

Other Revenue $0

TOTAL REVENUE $1,465,263

Expense Breakdown

Grants Paid $292,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $322,946

Other Expenses $38,368

TOTAL EXPENSES $330,368

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,465,263	$432,152	+2.4%
Expenses	$330,368	$230,111	+0.4%
Net Income	$1,134,895	$202,041	+4.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Sharon Anderson	President	10	Officer Director Key Emp	$0	$0	$0
Denice Brice	Secretary	2	Director Key Emp	$0	$0	$0
Howard Smith	Dir	0	Key Emp	$0	$0	$0
Edward Kurtz	Treasurer and V. President	2	Key Emp	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,465,263	$330,368	$2,077,910	$1,134,895
2023	$432,152	$230,111	$915,978	$202,041
2022	$374,295	$225,656	$715,769	$148,639
2021	$293,809	$273,734	$567,130	$20,075

LMSARCOMA DIRECT RESEARCH FOUNDATION